Clinical activity of P-BCMA-ALLO1, a B-cell maturation antigen (BCMA) targeted allogeneic chimeric antigen receptor T-cell (CAR-T) therapy, in relapsed refractory multiple myeloma (RRMM) patients (pts) following progression on prior BCMA targeting therapy

被引：2
|
作者：
Dholaria, Bhagirathbhai
Shune, Leyla
Kin, Andrew
McArthur, Katherine
Eskew, Jeff D.
Martin, Christopher E.
Haag, Sabrina
McCaigue, Joanne
Namini, Hamid
DePrimo, Sam
Cranert, Stacey
Coronella, Julia
Shedlock, Devon
Belani, Rajesh
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2024-CT071
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT071
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Long-Term Follow-up of a Phase 1, Firstin-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)
    Wang, Bai-Yan
    Zhao, Wan-Hong
    Liu, Jie
    Chen, Yin-Xia
    Cao, Xing-Mei
    Yang, Yun
    Zhang, Yi-Lin
    Wang, Fang-Xia
    Zhang, Peng-Yu
    Lei, Bo
    Gu, Liu-Fang
    Wang, Jian-Li
    Zhang, Jia-Jia
    Zhang, Ru
    Zhang, Hui
    Shen, Ying
    Bai, Ju
    Xu, Yan
    Wang, Xu-Geng
    Zhang, Rui-Li
    Wei, Li-Li
    Li, Zong-Fang
    He, Gai-Xia
    Geng, Yan
    He, Qian
    Zhuang, Qiu-Chuan
    Fan, Frank Xiao-Hu
    Zhang, Wang-Gang
    He, Ai-Li
    BLOOD, 2019, 134
  • [32] Clinical responses and pharmacokinetics of fully human BCMA targeting CAR T-cell therapy in relapsed/refractory multiple myeloma.
    Li, Chunrui
    Zhou, Jianfeng
    Wang, Jue
    Hu, Guang
    Du, Aihua
    Zhou, Xiaoxi
    Meng, Li
    Hong, Zhenya
    Chen, Liting
    Mao, Xia
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Clinical Responses and Pharmacokinetics of fully human BCMA Targeting CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Li, Chunrui
    Zhou, Xiaoxi
    Wang, Jue
    Hu, Guang
    Yang, Yongkun
    Meng, Li
    Hong, Zhenya
    Chen, Liting
    Zhou, Jianfeng
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E23 - E24
  • [34] OVERALL RESPONSE AND COMPLETE RESPONSE WITH ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY FOR RELAPSED AND REFRACTORY MULTIPLE MYELOMA (RRMM) : A SYSTEMATIC REVIEW AND META-ANALYSIS
    Aggarwal, S.
    Bela, A.
    Topaloglu, O.
    VALUE IN HEALTH, 2020, 23 : S25 - S25
  • [35] Clinical outcomes of relapsed/refractory multiple myeloma patients after BCMA-targeted CAR T therapy
    Van Oekelen, Oliver
    Mouhieddine, Tarek
    Pan, Darren
    Metzger, Megan
    Agte, Sarita
    Aleman, Adolfo
    Melnekoff, David
    Lancman, Guido
    Lagana, Alessandro
    Richard, Shambavi
    Sanchez, Larysa
    Richter, Joshua
    Cho, Hearn Jay
    Chari, Ajai
    Jagannath, Sundar
    Parekh, Samir
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S38 - S38
  • [36] P-BCMA-ALLO1-a nonviral, allogeneic anti-BCMA CAR-T therapy with potent antitumor function for the treatment of multiple myeloma
    Richter, Maximilian
    Cranert, Stacey
    Tan, Yening
    Tong, Min
    Domingo, Christine
    Argus, Elvira
    Ibitokou, Samad
    Smith, Jenessa
    Martin, Christopher
    Wang, Xinxin
    Barnett, Burton
    Ostertag, Eric
    Coronella, Julia
    Shedlock, Devon
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [37] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
    He, Shao-long
    Cheng, Yu-hang
    Wang, Di
    Xu, Meng-lei
    Que, Yi-mei
    Xu, Yan-jie
    Ma, Liang-ming
    Li, Chun-rui
    Zhou, Jian-feng
    CURRENT MEDICAL SCIENCE, 2021, 41 (03) : 474 - 481
  • [38] Efficacy and Safety of Fully Human Bcma Targeting CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Li, Chunrui
    Wang, Jue
    Wang, Di
    Hu, Guang
    Yang, Yongkun
    Zhou, Xiaoxi
    Meng, Li
    Hong, Zhenya
    Chen, Liting
    Mao, Xia
    Xiao, Min
    Zhou, Jianfeng
    BLOOD, 2019, 134
  • [39] Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy
    Samer Al Hadidi
    Aniko Szabo
    Jean Esselmann
    Lindsay Hammons
    Munawwar Hussain
    Yetunde Ogunsesan
    Nishanth Thalambedu
    Fatima Khan
    Jaskirat Sethi
    Abhishek Janardan
    Sabarinath Venniyil Radhakrishnan
    Sharmilan Thanendrarajan
    Carolina Schinke
    Binod Dhakal
    Siegfried Janz
    Saurabh Chhabra
    Anita D’Souza
    Maurizio Zangari
    Frits van Rhee
    Meera Mohan
    Bone Marrow Transplantation, 2023, 58 : 443 - 445
  • [40] Anti-BCMA CAR-T Cell Therapy in Relapsed or Refractory Multiple Myeloma Patients with Impaired Renal Function
    Shao-long He
    Yu-hang Cheng
    Di Wang
    Meng-lei Xu
    Yi-mei Que
    Yan-jie Xu
    Liang-ming Ma
    Chun-rui Li
    Jian-feng Zhou
    Current Medical Science, 2021, 41 : 474 - 481
12345